IL17A and psoriasis: Regarding inhibitory cytokines, several studies have found decreased expression of IL-38 in both skin and blood of psoriasis patients, whereas its expression was increased in normal skin and upregulated in lesional psoriasis following treatment with anti-IL-17A biologic agents [52,53,54].